Lifeboat Foundation

Amazon has repeatedly proven its might in disrupting legacy industries. Healthcare will be no different.

But they also request that Nvidia remove the mining performance limiter itself.

Following last week’s purported hack conducted by South-America-based Lapsus$ group, the hackers have now started to release data obtained from the 1 TB-worth of stolen information — and threaten to release a mining performance unlocker should Nvidia not do it first.

Researchers at the Northwestern University and Weinberg College of Arts and Sciences may have potentially come across a kilonova afterglow, the first of its kind ever to be observed, according to a university press release.

A kilonova is the merger of two neutron stars that creates a blast 1,000 times brighter than a classical nova. On August 17, 2017, astronomers observed the first-ever neutron star merger, GW170817, using light as well as gravitational waves. Ever since researchers across the globe have been pointing ground and space telescopes towards this event to study it across the electromagnetic spectrum.

There’s only one Universal Consciousness, we individualize our conscious awareness through the filter of our nervous system, our “local” mind, our very inner subjectivity, but consciousness itself, the Self in a greater sense, our “core” self is universal, and knowing it through experience has been called enlightenment, illumination, awakening, or transcendence, through the ages.

Here’s Consciousness: Evolution of the Mind (2021), Part IV: UNIVERSAL CONSCIOUSNESS

Continue reading “Universal Consciousness | Part IV of Consciousness: Evolution of the Mind (2021) Documentary” »

A major breakthrough in quantum sensing technology is being described as an “Edison moment” that could, scientists hope, have wide-reaching implications.

A new study in Nature describes one of the first practical applications of quantum sensing, a heretofore largely theoretical technology that marries quantum physics and the study of Earth’s gravity to peer into the ground below our feet — and the scientists involved in this research think it’s going to be huge.

Known as a quantum gravity gradiometer, this new sensor developed by the University of Birmingham under contract with the United Kingdom’s Ministry of Defense is the first time such a technology has been used outside of a lab. Scientists say it’ll allow them to explore complex underground substructures much more cheaply and efficiently than before.

Lattice confinement fusion eliminates massive magnets and powerful lasers.

Is the Chief Medical Officer at Current Health (https://currenthealth.com/), a Best Buy Health company (https://healthcare.bestbuy.com/) and part of the American multinational consumer electronics retailer.

Current Health is an organization that enables the delivery of healthcare services in the home to enable healthcare organizations to deliver high-quality, patient-centric care at a lower cost. The company integrates patient-reported data with data from biosensors – including their own continuous monitoring wearable devices – to provide healthcare organizations with actionable, real-time insights into the patient’s condition. Leveraging clinical algorithms that can be tailored to the individual patient, Current Health identifies when a patient needs clinical attention, allowing organizations to manage patient care remotely or coordinate in-home care via integrated service partners. The Current Health platform brings together tele-health capabilities, patient engagement tools, and in-home connectivity to provide a single solution to manage all care in the home. Dr. Wolfberg also leads implementation and account management at the organization.

Continue reading “Dr. Adam Wolfberg, MD, MPH — Chief Medical Officer, Current Health — Quality Healthcare In The Home” »

Alterra Property and Embark are forming an alliance to create autonomous-trucking hubs across the U.S.

Ending the latest chapter in a years-long legal battle over who invented CRISPR, the U.S. Patent and Trademark Office ruled on Monday that the revolutionary genome editing technology belongs to the Broad Institute of Harvard and MIT.

The decision is a blow to the University of California and biotech companies that had licensed the technology from the university for use in developing treatments, including Intellia Therapeutics and CRISPR Therapeutics. They will now have to negotiate with the Broad Institute for the right to use CRISPR for human therapies.